Bhavik Enterprises will hold a board meeting on 30 October 2026 to consider unaudited half-yearly results. Trading window stays closed until 1 November 2026.
Great Eastern Shipping contracted to buy a secondhand 82,000 cbm VLGC, joining its fleet in Q3 FY27. The vessel is funded from internal accruals to expand capacity.
Welspun Living has scheduled a board meeting on 30 October 2026 to approve Q2 and half-year unaudited results. The trading window stays closed until 48 hours after results are published.
Triveni Power Transmission appointed M/s Sanjay Grover & Associates as Secretarial Auditor, effective 01-04-2026, for a 60-month term. This is a routine auditor appointment with no monetary value.
Ace Engitech scheduled a board meeting on October 31, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 2, 2026.
Shadowfax Technologies will hold a board meeting on 29 October 2026 to approve September 2026 quarter results. An earnings call follows the same day at 5 p.m.
TruAlt Bioenergy reported H1 FY27 revenue of ₹1,437.98 crore, EBITDA of ₹233.92 crore and PAT of ₹94.27 crore via press release. Results reverse last year's H1 loss.
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Shlokka Dyes disclosed that Company Secretary and Compliance Officer Siddharth Parshottam Gajra resigned, effective close of business October 31, 2026. He cited pursuing other professional opportunities.
Gufic Biosciences reported a USFDA pre-approval inspection at its Indore facility, concluding October 23, 2026. The inspection produced three Form 483 observations, now being addressed.
Sat Kartar Life's EGM covered one special resolution to issue fully convertible warrants to promoter group on preferential basis. Voting results follow within two working days.
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Biogen Pharmachem Industries Ltd intimated a board meeting on 3 November 2026 to approve unaudited results for Q2 and half year ended 30 September 2026. The filing is a meeting notice only, with no monetary event.
Panache Digilife allotted 1,60,300 equity shares on conversion of preferential warrants after receiving Rs 3.16 Crore in exercise money. Paid-up capital rises to Rs 16.17 Crore.
Chennai Petroleum Corporation appointed R G N Price & Co as statutory auditor for a 12-month term, effective 22 October 2026. The appointment follows a board meeting held that day.
Suncare Traders Limited intimated a board meeting on 3 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The agenda is proposed only and the meeting has not yet been held.
E To E Transportation initiated pre-institution mediation under Section 12A against M/s Jhajharia Nirman over outstanding dues from four work orders. The company claims ₹8.20 Crore, while the counterparty counterclaims ₹3.14 Crore.
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.